{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06396078",
            "orgStudyIdInfo": {
                "id": "2024H0122"
            },
            "organization": {
                "fullName": "Ohio State University",
                "class": "OTHER"
            },
            "briefTitle": "Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)",
            "officialTitle": "Improvement of PPROM Management With Prophylactic Antimicrobial Therapy",
            "therapeuticArea": [
                "Women's Health",
                "Other"
            ],
            "study": "improvement-of-pprom-management-with-prophylactic-antimicrobial-therapy-iprompt"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-25",
            "studyFirstSubmitQcDate": "2024-05-01",
            "studyFirstPostDateStruct": {
                "date": "2024-05-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Kartik K Venkatesh",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Ohio State University"
            },
            "leadSponsor": {
                "name": "Ohio State University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "To conduct an unblinded pragmatic randomized controlled trial (pRCT) \"Improvement of PPROM Management with Prophylactic Antimicrobial Therapy (iPROMPT)\" of a seven-day course of ceftriaxone, clarithromycin, and metronidazole versus the current standard of care of a seven-day course of ampicillin/amoxicillin and azithromycin or erythromycin to prolong pregnancy and decrease adverse perinatal outcomes among hospitalized pregnant individuals undergoing expectant management of PPROM \\<34 weeks.",
            "detailedDescription": "Preterm prelabor rupture of membranes (PPROM) is the most common identifiable risk factor associated with preterm birth and affects 1 in 3 pregnant individuals in the United States with spontaneous preterm birth. Individuals diagnosed with PPROM who meet criteria for expectant management are currently admitted to the hospital for observation until delivery, which is generally recommended at 34 weeks' gestation unless indicated sooner. Initially upon admission, a course of prophylactic antibiotics is administered as this has been shown to prolong pregnancy and improve neonatal outcomes. The standard antibiotic regimen, primarily based on data published in 1997, includes ampicillin followed by amoxicillin with erythromycin or azithromycin for a total of 7 days. Ongoing studies are needed to determine the optimal prophylactic antibiotic regimen given changes in bacterial sensitivities over time, lack of adequate coverage for common organisms including genital mycoplasma, inadequate placental transfer of currently used antibiotic agents, ineffective antibiotic response at reducing the fetal inflammatory response, and new promising antibiotic agents that address these limitations. A promising expanded-spectrum alternative regimen with proof-of-concept is ceftriaxone, clarithromycin, and metronidazole. Observational studies have shown successful eradication of intraamniotic inflammation/infection using this new regimen. This regimen offers multiple potential advantages, including: higher bioavailability, higher transplacental transfer, and effectiveness against genital mycoplasma (clarithromycin), greater anaerobic coverage (metronidazole), and a longer half-life and expanded coverage against gram-negative bacteria (ceftriaxone) compared with the current standard regimen."
        },
        "conditionsModule": {
            "conditions": [
                "Preterm Premature Rupture of Membrane",
                "Pregnancy, High Risk",
                "Preterm Birth"
            ],
            "keywords": [
                "Pregnancy",
                "Preterm premature rupture of membranes",
                "Latency",
                "Chorioamnionitis",
                "Antibiotic prophylaxis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 56,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intervention group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants randomized to the intervention group will receive the following regimen:\n\n* Ceftriaxone 1 g IV q 24 hours x 7 days\n* Clarithromycin 500 mg PO BID x 7 days\n* Metronidazole 500 mg PO q 12 hours x 7 days",
                    "interventionNames": [
                        "Drug: Ceftriaxone 1000 MG",
                        "Drug: Clarithromycin 500mg",
                        "Drug: Metronidazole 500 mg"
                    ]
                },
                {
                    "label": "Standard of care",
                    "type": "OTHER",
                    "description": "Participants randomized to the standard care group will receive the following regimen:\n\n* Ampicillin 2 g IV q 6 hours x 48 hours followed by amoxicillin 250 mg q 8 hours for an additional 5 days\n* Azithromycin 1 g PO x 1 dose OR erythromycin 250 mg IV q 6 hours x 48 hours followed by erythromycin 333 mg PO TID for an additional 5 days",
                    "interventionNames": [
                        "Drug: Ampicillin 2 GM Injection",
                        "Drug: Amoxicillin 250 MG",
                        "Drug: Azithromycin",
                        "Drug: Erythromycin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ceftriaxone 1000 MG",
                    "description": "Ceftriaxone 1 g IV q 24 hours x 7 days (in addition to clarithromycin and metronidazole)",
                    "armGroupLabels": [
                        "Intervention group"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Clarithromycin 500mg",
                    "description": "Clarithromycin 500 mg PO BID x 7 days (in addition to ceftriaxone and metronidazole)",
                    "armGroupLabels": [
                        "Intervention group"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Metronidazole 500 mg",
                    "description": "Metronidazole 500 mg PO q 12 hours x 7 days (in addition to clarithromycin and ceftriaxone)",
                    "armGroupLabels": [
                        "Intervention group"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ampicillin 2 GM Injection",
                    "description": "Ampicillin 2 g IV q 6 hours x 48 hours (prior to amoxicillin and in addition to either azithromycin or erythromycin)",
                    "armGroupLabels": [
                        "Standard of care"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Amoxicillin 250 MG",
                    "description": "Amoxicillin 250 mg q 8 hours for an additional 5 days (following ampicillin and in addition to either azithromycin or erythromycin)",
                    "armGroupLabels": [
                        "Standard of care"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Azithromycin",
                    "description": "Azithromycin 1 g PO x 1 dose (in addition to ampicillin and amoxicillin)",
                    "armGroupLabels": [
                        "Standard of care"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Erythromycin",
                    "description": "Erythromycin 250 mg IV q 6 hours x 48 hours followed by erythromycin 333 mg PO TID for an additional 5 days (in addition to ampicillin and amoxicillin)",
                    "armGroupLabels": [
                        "Standard of care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Latency",
                    "description": "Latency will be measured in hours, and also reported as days for clinical interpretability.",
                    "timeFrame": "From randomization to delivery"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Neonatal outcome composite checklist",
                    "description": "Includes neonatal sepsis, respiratory distress syndrome, any mechanical ventilation, bronchopulmonary dysplasia, intraventricular hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, stillbirth, or neonatal death",
                    "timeFrame": "From birth to up to 6 weeks postpartum"
                },
                {
                    "measure": "Endometritis",
                    "description": "Diagnosed If the patient develops two of the following 1) oral body temperature \u2265101\u00b0F at any time, or a temperature of \u2265100.4 \u00b0F 24 hours after delivery, 2) maternal tachycardia that parallels the temperature, 3) uterine tenderness, 4) purulent vaginal discharge, or 5) associated findings with advanced endometritis (dynamic ileus, pelvic peritonitis, pelvic abscess, bowel obstruction, necrosis of the lower uterine segment)",
                    "timeFrame": "From birth to up to 6 weeks postpartum"
                },
                {
                    "measure": "Surgical site infection",
                    "description": "Presence of either superficial or deep incisional SSI described as cellulitis/erythema and induration around the incision or purulent discharge from the incision site, with or without fever, such as necrotizing fasciitis (diagnosed based on necrotizing wound infection). Intraabdominal abscess may or may not be present. Wound hematoma, seroma, or incisional breakdown alone in the absence of the above signs does not constitute infection.",
                    "timeFrame": "From birth to up to 6 weeks postpartum"
                },
                {
                    "measure": "Individual clinical infections",
                    "timeFrame": "From birth to up to 6 weeks postpartum"
                },
                {
                    "measure": "Puerperal fever",
                    "description": "temperature \u2265 100.4 \u00b0F at least twice 30 minutes apart, or once with the use of antipyretic, or \u2265 101 \u00b0F once. This will be analyzed for intrapartum and postpartum fever.",
                    "timeFrame": "From birth to up to 6 weeks postpartum"
                },
                {
                    "measure": "Histopathologic chorioamnionitis/funisitis on histologic placental evaluation",
                    "timeFrame": "From randomization to delivery"
                },
                {
                    "measure": "Antibiotic receipt postpartum",
                    "timeFrame": "From birth to up to 6 weeks postpartum"
                },
                {
                    "measure": "Adverse events",
                    "description": "Allergic reactions (anaphylaxis, angioedema, urticaria), Stevens Johnsons syndrome, gastrointestinal side effects (nausea, vomiting, constipation, diarrhea, ileus)",
                    "timeFrame": "From randomization to delivery"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria\n\n* Admitted to the inpatient unit for expectant management of PPROM until delivery\n* Age \u2265 18 years with the ability to provide informed consent\n* Gestational age between 23 0/7 and 32 6/7 weeks\n\nExclusion criteria\n\n* Having received more than one dose of any prophylactic antibiotic\n* Suspected or confirmed infection requiring treatment with antibiotics\n* Allergy or contraindication to an antibiotic in either arm\n* Maternal immunosuppression",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "This study is restricted to pregnant individuals.",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Marissa Berry, MD",
                    "role": "CONTACT",
                    "phone": "614-293-4780",
                    "email": "Marissa.Berry@osumc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Marissa Berry, MD",
                    "affiliation": "Ohio State University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Kartik K Venkatesh, MD, PhD",
                    "affiliation": "Ohio State University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marissa Berry, MD",
                            "role": "CONTACT",
                            "phone": "614-293-4780",
                            "email": "Marissa.Berry@osumc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000047928",
                    "term": "Premature Birth"
                },
                {
                    "id": "D000005322",
                    "term": "Fetal Membranes, Premature Rupture"
                },
                {
                    "id": "D000012421",
                    "term": "Rupture"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007752",
                    "term": "Obstetric Labor, Premature"
                },
                {
                    "id": "D000007744",
                    "term": "Obstetric Labor Complications"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M25869",
                    "name": "Premature Birth",
                    "asFound": "Preterm",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15241",
                    "name": "Rupture",
                    "asFound": "Rupture",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8452",
                    "name": "Fetal Membranes, Premature Rupture",
                    "asFound": "Premature Rupture of Membranes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6061",
                    "name": "Chorioamnionitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10772",
                    "name": "Obstetric Labor, Premature",
                    "relevance": "LOW"
                },
                {
                    "id": "M10764",
                    "name": "Obstetric Labor Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000658",
                    "term": "Amoxicillin"
                },
                {
                    "id": "D000017963",
                    "term": "Azithromycin"
                },
                {
                    "id": "D000008795",
                    "term": "Metronidazole"
                },
                {
                    "id": "D000017291",
                    "term": "Clarithromycin"
                },
                {
                    "id": "D000002443",
                    "term": "Ceftriaxone"
                },
                {
                    "id": "D000004917",
                    "term": "Erythromycin"
                },
                {
                    "id": "D000004918",
                    "term": "Erythromycin Estolate"
                },
                {
                    "id": "D000015643",
                    "term": "Erythromycin Ethylsuccinate"
                },
                {
                    "id": "C000011462",
                    "term": "Erythromycin stearate"
                },
                {
                    "id": "D000000667",
                    "term": "Ampicillin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000000981",
                    "term": "Antiprotozoal Agents"
                },
                {
                    "id": "D000000977",
                    "term": "Antiparasitic Agents"
                },
                {
                    "id": "D000011500",
                    "term": "Protein Synthesis Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000065692",
                    "term": "Cytochrome P-450 CYP3A Inhibitors"
                },
                {
                    "id": "D000065607",
                    "term": "Cytochrome P-450 Enzyme Inhibitors"
                },
                {
                    "id": "D000097911",
                    "term": "Third Generation Cephalosporins"
                },
                {
                    "id": "D000097902",
                    "term": "Beta Lactam Antibiotics"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5693",
                    "name": "Ceftriaxone",
                    "asFound": "DHA",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3995",
                    "name": "Amoxicillin",
                    "asFound": "Movement",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19585",
                    "name": "Clarithromycin",
                    "asFound": "Cuff",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M4003",
                    "name": "Ampicillin",
                    "asFound": "Insight",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11767",
                    "name": "Metronidazole",
                    "asFound": "Beginning",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20132",
                    "name": "Azithromycin",
                    "asFound": "Fasting",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8068",
                    "name": "Erythromycin",
                    "asFound": "Proof of Concept Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8069",
                    "name": "Erythromycin Estolate",
                    "asFound": "Proof of Concept Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18236",
                    "name": "Erythromycin Ethylsuccinate",
                    "asFound": "Proof of Concept Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M195803",
                    "name": "Erythromycin stearate",
                    "asFound": "Proof of Concept Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4298",
                    "name": "Antiprotozoal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4294",
                    "name": "Antiparasitic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M30564",
                    "name": "Cytochrome P-450 CYP3A Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M30537",
                    "name": "Cytochrome P-450 Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5760",
                    "name": "Cephalosporins",
                    "relevance": "LOW"
                },
                {
                    "id": "M3453",
                    "name": "Third Generation Cephalosporins",
                    "relevance": "LOW"
                },
                {
                    "id": "M10789",
                    "name": "Lactams",
                    "relevance": "LOW"
                },
                {
                    "id": "M25772",
                    "name": "beta-Lactams",
                    "relevance": "LOW"
                },
                {
                    "id": "M3444",
                    "name": "Beta Lactam Antibiotics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}